Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
POST FORUM REPORT
5TH
EPP Life Sciences
PRICING FORUM
focusing on Pricing,
Profit Optimisation
and business monetisation
S...
| European Pricing Platform2
Top speakers
100+
target group participants
25
speakers
5
hours of plenary sessions
2
hours o...
3
Top presentations
Break-out sessions
Some of the highlights
From a ‘strategy’ point of view
‘Readiness for pricing and m...
| European Pricing Platform4
Testimonials •	A good conference balancing theo-
ry and practical cases, also allowing
discus...
Post Forum Report 2015 | 5
•  Johnson & Johnson
•  Novartis
•  Pfizer
•  Roche
•  Sanofi
•  Glaxo Smith Kline
•  Fresenius...
| European Pricing Platform6
Times are changing and they’re
changing faster than ever. In particular
the Life Sciences com...
Post Forum Report 2015 | 7
Formula Standard rates Quantity
Pre forum workshop € 895
EPP Life Sciences Pricing Forum 2016 (...
Upcoming SlideShare
Loading in …5
×

0

Share

Download to read offline

Post Forum Report on the 5th EPP Life Sciences Pricing Forum

Download to read offline

This document gives you a short take-away on the 5th Life Sciences Pricing forum that took place in Montreux, Switzerland on September 22-23, 2015

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all
  • Be the first to like this

Post Forum Report on the 5th EPP Life Sciences Pricing Forum

  1. 1. POST FORUM REPORT 5TH EPP Life Sciences PRICING FORUM focusing on Pricing, Profit Optimisation and business monetisation SEPTEMBER 22-23, 2015 MONTREUX, Switzerland in partnership with
  2. 2. | European Pricing Platform2 Top speakers 100+ target group participants 25 speakers 5 hours of plenary sessions 2 hours of panel discussion and roundtables 15 participating countries The forum in numbers 6 hours of break-out sessions, for pharma/generics/biotech as well as medtech tracks Benoît Miry International Market Access Manager Menarini, Luxembourg Bertrand Tardival Head of Global Pricing Takeda Pharmaceuticals, Switzerland Tim Nugent Managing Director KPMG, USA Gustav Ando Director Life Sciences HIS, UK Gary Watson Executive VP Alliance Life Sciences, USA Marc Matar Senior Director Simon-Kucher & Partners, UK Arnab Sikder Senior VP European Operations Highpoint Solutions, Switzerland Dirk Scholdei Senior Pricing Manager Philips Healthcare, Germany Florian Turk VP Head Global Market Access & Healthcare Solutions GSK, UK Gustavo Saraiva Director Pricing Capability Otsuka Pharmaceuticals Europe, UK Simone Leone Director Sales & Pricing Effectiveness Europe Boston Scientific Corporation, Italy Christian Rebholz Director Simon-Kucher & Partners, Germany Joanna Koulos Panagopoulos Senior Manager Strategic Pricing Sup- port & analytics Boston Scientific Corporation, USA Emilio Borin EMEA Pricing Manager Corning, Italy Tsveta Milanova VP Corporate Pricing & Market Access Celgene, USA Raymond J. Almeida Jr. VP Global Reporting & Analytics Boston Scientific Group, USA Carina Schey Guest Researcher University of Groningen, UK Mondher Toumi Professor Public Health Research Unit Aix-Marseille University, France Joost Visser Strategy Department Director Boobook, Belgium Hanno Wolfram Director Innov8, Germany Madalina Lavinia Preda Customer Experience Manager Corning, The Netherlands Alan Crowther CEO Alliance Life Sciences, USA Tobias Happel Global Pricing Manager Philips Healthcare, Germany Patrick Palluel Head of Pricing & Tender Strategy Sanofi Pasteur MSD, France Carl Poland Business Professional Finance/ Accounting Mylan Pharmaceuticals, USA
  3. 3. 3 Top presentations Break-out sessions Some of the highlights From a ‘strategy’ point of view ‘Readiness for pricing and market access 2020” by prof. M. Toumi From a ‘planning’ point of view ‘Shaping up for the future: a vision on the future of strategic pricing & profit optimization capabilities’ by Florian Turk from GSK • Practitioner and consultant join for- ces or how KPMG and Mylan Pharma- ceuticals learn from each other. • A vivid panel discussion with views from different angles: a practitioner, a consultant and an academic on ‘how to respond to a price transparent world?’ • Several break-out session on price setting, pricing models, pricing techniques, gross to net, tender stra- tegy presented by top speakers. • How Philips Healthcare was able to establish a margin impact of 1M Euro? • Prof. Toumi speaking about the readiness for pricing and market ac- cess 2020. A great opening session! • Roundtables on several topics: demystifyind big data, the value of the pricing function in a company, the im- pact of a pricing group in a company. • A great evening event: dinner and winetasting in the Lavaux Vineyards, Unesco World Heritage. Break-out sessions in the pharma track with • Bertrand Tardivel, Takeda Pharmaceuticals • Benoit Miry, Menarini Group • Gustavo Saraivo, Otsuka Pharmaceuticals • Patrick Palluel, Sanofi Pasteur MSD • Carina Schey, University of Groningen Break-out sessions in the medtech track with • Tobias Happel & Dirk Scholdei, Philips Healthcare • Simon Leone, Boston Scientific • Christian Rebholz, Simon-Kucher & Partners From an ‘execution’ point of view ‘A global overview of revenue ma- nagement’ by Tim Nugent, KPMG and Carl Poland, Mylan Pharmaceuticals ‘Drugs: price or value?’ by Hanno Wolfram from Innov8 Post Forum Report 2015 |
  4. 4. | European Pricing Platform4 Testimonials • A good conference balancing theo- ry and practical cases, also allowing discussions and interactions among speakers and members of the audi- ence. Strongly recommended for those in- teresting in pricing aspects looking for something enriching. P. Palluel, Head of Pricing and Tender Strategy • ‘I’m open to the discussion to shar- pen the mind. This is a really good en- vironment to be in.’ Klaas Postema, Executive Director, Actavis Geographical distribution 3% 16%81% Europe North America Other Our thanks goes out to • Our partner and sponsors for sup- porting us before, during and after the event. • Our speakers for lifting this 5th EPP Life Sciences Pricing forum to a high level of knowledge and experience sharing. • And of course, our delegates for making this a to-the-point forum for every one present. Britt Dejager Life Sciences Industry Manager • ‘I really like the topics and the way it is set up. It triggers the right ques- tions!’ Nico Bacharidis, Global Tender & Contracting Lead GEP, Pfizer • ‘Bringing together a diverse range of stakeholders, with not only focus on the issues and difficulties that pharma companies are faced with, but also what the solutions are. And that is a key differentiator!’ Gustav Ando, Analyst Global Life Sciences, IHS I was very delighted to meet you all in the magnificent town of Montreux, for the 5th consecutive time. I hope the forum has met your expectations and I’m already working on a 6th – even better – edition of the EPP Life Scien- ces Pricing Forum. I hope to see you all again for some new insights, net- working opportunities and moments of discussion and reflection. 78% of the attendees would recommend the Life Sciences Forum to a colleague/peer. 83% is very likely to attend next year’s edition. 80/20 EPP will keep watch to ensure this ratio of practitioners and experts* on all our events. * experts: consultants, pricing software ven- dors, research and implementation experts How did the delegates benefit?
  5. 5. Post Forum Report 2015 | 5 • Johnson & Johnson • Novartis • Pfizer • Roche • Sanofi • Glaxo Smith Kline • Fresenius • Astra Zeneca • Teva Pharmaceuticals • Amgen • General Electric • Medtronic • Takeda Pharmaceuticals • Philips Healthcare • Stryker • Mylan • Celgene • Shire • Otsuka • Getinge • Lundbeck • Sonova • Coloplast • Actelion • Biogen • Medela • Astellas • Nestle • Novo Nordisk • Menarini • Boehringer Ingelheim • Paddock • Alexion • Corning • Thermo Fisher • Ferring • BD • Ironwood • Almirall • Revitas • Simon-Kucher & Partners • HIS • KPMG • Boston Scientific Corporation Participating  companies Our partner and sponsors simon kucher & partners Strategy & Marketing Consultants
  6. 6. | European Pricing Platform6 Times are changing and they’re changing faster than ever. In particular the Life Sciences companies have to be innovative and respond quickly to market changes. Price & margin ero- sion, international reference pricing, loss of exclusivity, new discount and rebate structures ask for new skills, a clear strategy and new insights to ensure profit optimisation. As a main profit driver, your pricing strategy needs to meet your future pricing organizational challenges. And that is how the EPP Life Sciences Pricing Forum can help you. • Meet with your peers and discuss the opportunities and challenges they are facing. • Learn from industry experts who will share with all of us their know-how and insights. • Discover real business cases across Pharma-Biotech and Medtech. Reflection, discussion, learning and networking are our main objectives. So that you can return back and be able to define your own action plan, eliminate risk , optimize sales effecti- veness and enhance revenue growth! 5 reasons why you should attend 1 Agenda topics being finetuned with key industry influencers who take up res- ponsibility in the EPP Steering Committee. 2 Roundtables bringing together the strategic de- cision makers, a guarantee for strong interaction. 3 Smart Exchange sessions will help to learn and even unlearn, but certainly brain- storm and inspire. 4 Top keynote speakers with relevant know-how and lessons learned. 5 And of course our free evening networking event: dinner with a touch of learning Join us at the 6th EPP Life Sciences Pricing Forum in Montreux, Switzerland on September 20-21, 2016. Register now and profit from • Early Bird ticket (valid until June 12, 2016) • Group Rate ticket http://www.pricingevents.eu/events/6th-epp-life-sciences-forum-2015/#tickets 6TH EPP Life Sciences PRICING FORUM SEPTEMBER 20-21, 2016 | MONTREUX
  7. 7. Post Forum Report 2015 | 7 Formula Standard rates Quantity Pre forum workshop € 895 EPP Life Sciences Pricing Forum 2016 (2 day forum) € 1.595 Pre forum workshop + 2 day forum € 2.495 Consultants & software vendors € 2.995 Last Name: First Name: Function: Company: Business Address: Postal Code / City: Country: VAT number (required): PO number required? ™ Yes (please fill in the PO number) ™ No Email: Telephone number: Fax number: Forum rates (in euro) Sign here to confirm your registration: Special requirements or requests: * Visit www.pricingplatform.eu for more information on EPP Participation ™ I wish to become an EPP Participant - Professional Plus, and immediately benefit from a free full access pass to the Life Sciences Pricing Forum 2016 Registration Form 6TH EPP life sciences Pricing Forum 2016 EPP Life Sciences Pricing Forum 2016: SEPTEMBER 20TH - 21ST , 2016 | MONTREUX Do you prefer to register online? Visit www.pricingevents.eu and fill out the online registration form Your registration is complete after payment Follow this link to read the terms and conditions Fax this form to +32/51.32.03.73 or mail an electronic copy to: britt.dejager@pricingplatform.eu After receiving your registration request, an EPP team member will contact you to complete the registration. EPP Participants benefit from 10% reduction or a full free access pass to the Life Sciences Pricing Forum 2016*

This document gives you a short take-away on the 5th Life Sciences Pricing forum that took place in Montreux, Switzerland on September 22-23, 2015

Views

Total views

1,009

On Slideshare

0

From embeds

0

Number of embeds

11

Actions

Downloads

5

Shares

0

Comments

0

Likes

0

×